EXPERIMENTAL-MODELS OF INFLAMMATORY BOWEL-DISEASE

被引:0
|
作者
LOUIS, E
BELAICHE, J
机构
来源
ACTA GASTRO-ENTEROLOGICA BELGICA | 1994年 / 57卷 / 5-6期
关键词
CROHNS DISEASE; PATHOPHYSIOLOGY;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Etiology of inflammatory bowel disease (IBD) is still unknown, A lot of experimental models of these diseases have been developed during the last years. They can be classified as spontaneous and induced models, Spontaneous models are infectious, genetic or of unknown etiology, Induced models are infectious, immune-mediated, chemical or genetic, All these models share some characteristics with IBD, In general, they are characterized by a chronic inflammation of the gut, and often, this inflammation appears secondarly to mucosal abnormalities leading to an abnormal immune and inflammatory response toward luminal material, The most interesting models are thus those that share not only clinical and pathological characteristics with IBD, but also early mucosal abnormalities. From that point of view, the nonsteroidal anti-inflammatory drug (NSAID) enteropathy is probably one of the most interesting model for Crohn's disease (CD), In effect, this model shares an early modification with Co, that is increased intestinal permeability, In animals NSAID enteropathy, the increased intestinal permeability appears early after NSAID administration and is followed by inflammatory lesions, These lesions seem to be secondary to the increased permeability and depend on intraluminal materials, such as alimentary antigens or bacterial fragments, A possible link between the Increased permeability and the inflammatory lesions could be an abnormal immune and inflammatory response toward the intraluminal materials, If the increased intestinal permeability in cc was confirmed, the same mechanisms could be implicated in its pathophysiology.
引用
收藏
页码:306 / 309
页数:4
相关论文
共 50 条
  • [31] GENETICALLY-ENGINEERED MODELS OF INFLAMMATORY BOWEL-DISEASE
    CONNER, EM
    AIKO, S
    GRISHAM, M
    CURRENT OPINION IN GASTROENTEROLOGY, 1994, 10 (04) : 358 - 364
  • [32] ANIMAL-MODELS OF INFLAMMATORY BOWEL-DISEASE - AN OVERVIEW
    STROBER, W
    DIGESTIVE DISEASES AND SCIENCES, 1985, 30 (12) : S3 - S10
  • [33] TOPICAL GLUTAMINE THERAPY IN EXPERIMENTAL INFLAMMATORY BOWEL-DISEASE
    NEILLY, PJD
    GARDINER, KR
    KIRK, SJ
    OHARE, M
    JENNINGS, G
    ANDERSON, NH
    ELIA, M
    ROWLANDS, BJ
    CLINICAL NUTRITION, 1995, 14 (05) : 283 - 287
  • [34] CYCLOSPORINE IN INFLAMMATORY BOWEL-DISEASE - STILL AN EXPERIMENTAL OPTION
    LAURITSEN, K
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1994, 6 (06) : 495 - 498
  • [35] EXPERIMENTAL-MODELS OF INFLAMMATORY MYOPATHIES
    ROSENBERG, NL
    BAILLIERES CLINICAL NEUROLOGY, 1993, 2 (03): : 693 - 715
  • [36] FREQUENCY OF INFLAMMATORY BOWEL-DISEASE IN OFFSPRING OF COUPLES BOTH PRESENTING WITH INFLAMMATORY BOWEL-DISEASE
    BENNETT, RA
    RUBIN, PH
    PRESENT, DH
    GASTROENTEROLOGY, 1991, 100 (06) : 1638 - 1643
  • [37] INFLAMMATORY INTERMEDIARIES IN INFLAMMATORY BOWEL-DISEASE
    LAURITSEN, K
    LAURSEN, LS
    BUKHAVE, K
    RASKMADSEN, J
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 1989, 4 (02) : 75 - 90
  • [38] INFLAMMATORY MEDIATORS IN INFLAMMATORY BOWEL-DISEASE
    STENSON, WF
    CURRENT OPINION IN GASTROENTEROLOGY, 1994, 10 (04) : 384 - 389
  • [39] INFLAMMATORY MEDIATORS OF INFLAMMATORY BOWEL-DISEASE
    COMINELLI, F
    KAM, L
    CURRENT OPINION IN GASTROENTEROLOGY, 1993, 9 (04) : 534 - 543
  • [40] Experimental models of inflammatory bowel disease
    Stadnicki, A
    Colman, RW
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2003, 51 (03) : 149 - 155